NAR cancer

Keyphrases

Publications

volume 6, number 2, 2024

Selina Shiqing K Teh, Kirsten Bowland, Eitan Halper-Stromberg, Akhil Kotwal, Alexis Bennett, Alyza Skaist, Jacqueline Tang, Fidel Cai, Antonella Macoretta, Hong Liang, Hirohiko Kamiyama, Sarah Wheelan, Ming-Tseh Lin, Ralph H Hruban, Chien-Fu Hung, Michael Goldstein, Robert B Scharpf, Nicholas J Roberts, James R Eshleman
CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers. NAR cancer 6 (2) (2024)
Selina Shiqing K Teh, Kirsten Bowland, Eitan Halper-Stromberg, Akhil Kotwal, Alexis Bennett, Alyza Skaist, Jacqueline Tang, Fidel Cai, Antonella Macoretta, Hong Liang, Hirohiko Kamiyama, Sarah Wheelan, Ming-Tseh Lin, Ralph H Hruban, Chien-Fu Hung, Michael Goldstein, Robert B Scharpf, Nicholas J Roberts, James R Eshleman
CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers. NAR cancer 6 (2) (2024)
Selina Shiqing K Teh, Kirsten Bowland, Eitan Halper-Stromberg, Akhil Kotwal, Alexis Bennett, Alyza Skaist, Jacqueline Tang, Fidel Cai, Antonella Macoretta, Hong Liang, Hirohiko Kamiyama, Sarah Wheelan, Ming-Tseh Lin, Ralph H Hruban, Chien-Fu Hung, Michael Goldstein, Robert B Scharpf, Nicholas J Roberts, James R Eshleman
CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers. NAR cancer 6 (2) (2024)
Rujuta Yashodhan Gadgil, S Dean Rider, Resha Shrestha, Venicia Alhawach, David C Hitch, Michael Leffak
Microsatellite break-induced replication generates highly mutagenized extrachromosomal circular DNAs. NAR cancer 6 (2) (2024)
Rujuta Yashodhan Gadgil, S Dean Rider, Resha Shrestha, Venicia Alhawach, David C Hitch, Michael Leffak
Microsatellite break-induced replication generates highly mutagenized extrachromosomal circular DNAs. NAR cancer 6 (2) (2024)
Rujuta Yashodhan Gadgil, S Dean Rider, Resha Shrestha, Venicia Alhawach, David C Hitch, Michael Leffak
Microsatellite break-induced replication generates highly mutagenized extrachromosomal circular DNAs. NAR cancer 6 (2) (2024)
Anne Cammas, Alice Desprairies, Erik Dassi, Stefania Millevoi
The shaping of mRNA translation plasticity by RNA G-quadruplexes in cancer progression and therapy resistance. NAR cancer 6 (2) (2024)
Annagiulia Ciocia, Neus Mestre-Farràs, Ignacio Vicent-Nacht, Tanit Guitart, Fátima Gebauer
CSDE1: a versatile regulator of gene expression in cancer. NAR cancer 6 (2) (2024)
Pia Hoellerbauer, Megan Kufeld, Sonali Arora, Kelly Mitchell, Emily J Girard, Jacob A Herman, James M Olson, Patrick J Paddison
FBXO42 activity is required to prevent mitotic arrest, spindle assembly checkpoint activation and lethality in glioblastoma and other cancers. NAR cancer 6 (2) (2024)
Annagiulia Ciocia, Neus Mestre-Farràs, Ignacio Vicent-Nacht, Tanit Guitart, Fátima Gebauer
CSDE1: a versatile regulator of gene expression in cancer. NAR cancer 6 (2) (2024)
Ángel-Carlos Román, Dixan A Benítez, Alba Díaz-Pizarro, Nuria Del Valle-Del Pino, Marcos Olivera-Gómez, Guadalupe Cumplido-Laso, Jose M Carvajal-González, Sonia Mulero-Navarro
Next generation sequencing technologies to address aberrant mRNA translation in cancer. NAR cancer 6 (2) (2024)
Anne Cammas, Alice Desprairies, Erik Dassi, Stefania Millevoi
The shaping of mRNA translation plasticity by RNA G-quadruplexes in cancer progression and therapy resistance. NAR cancer 6 (2) (2024)
Ángel-Carlos Román, Dixan A Benítez, Alba Díaz-Pizarro, Nuria Del Valle-Del Pino, Marcos Olivera-Gómez, Guadalupe Cumplido-Laso, Jose M Carvajal-González, Sonia Mulero-Navarro
Next generation sequencing technologies to address aberrant mRNA translation in cancer. NAR cancer 6 (2) (2024)
Tianhui Zhu, Atsushi Okabe, Genki Usui, Ryoji Fujiki, Daichi Komiyama, Kie Kyon Huang, Motoaki Seki, Masaki Fukuyo, Hiroyuki Abe, Meng Ning, Tomoka Okada, Mizuki Minami, Makoto Matsumoto, Qin Fan, Bahityar Rahmutulla, Takayuki Hoshii, Patrick Tan, Teppei Morikawa, Tetsuo Ushiku, Atsushi Kaneda
Integrated enhancer regulatory network by enhancer-promoter looping in gastric cancer. NAR cancer 6 (2) (2024)
Xingyuan Zhang, Sayali Joseph, Di Wu, Jessica L Bowser, Cyrus Vaziri
The DNA Damage Response (DDR) landscape of endometrial cancer defines discrete disease subtypes and reveals therapeutic opportunities. NAR cancer 6 (2) (2024)
Selina Shiqing K Teh, Kirsten Bowland, Eitan Halper-Stromberg, Akhil Kotwal, Alexis Bennett, Alyza Skaist, Jacqueline Tang, Fidel Cai, Antonella Macoretta, Hong Liang, Hirohiko Kamiyama, Sarah Wheelan, Ming-Tseh Lin, Ralph H Hruban, Chien-Fu Hung, Michael Goldstein, Robert B Scharpf, Nicholas J Roberts, James R Eshleman
CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers. NAR cancer 6 (2) (2024)
Selina Shiqing K Teh, Kirsten Bowland, Eitan Halper-Stromberg, Akhil Kotwal, Alexis Bennett, Alyza Skaist, Jacqueline Tang, Fidel Cai, Antonella Macoretta, Hong Liang, Hirohiko Kamiyama, Sarah Wheelan, Ming-Tseh Lin, Ralph H Hruban, Chien-Fu Hung, Michael Goldstein, Robert B Scharpf, Nicholas J Roberts, James R Eshleman
CRISPR-Cas9 for selective targeting of somatic mutations in pancreatic cancers. NAR cancer 6 (2) (2024)
Anwesha Dasgupta, John R Prensner
Upstream open reading frames: new players in the landscape of cancer gene regulation. NAR cancer 6 (2) (2024)
Rujuta Yashodhan Gadgil, S Dean Rider, Resha Shrestha, Venicia Alhawach, David C Hitch, Michael Leffak
Microsatellite break-induced replication generates highly mutagenized extrachromosomal circular DNAs. NAR cancer 6 (2) (2024)
Mélanie Mahé, Tiffany Rios-Fuller, Olga Katsara, Robert J Schneider
Non-canonical mRNA translation initiation in cell stress and cancer. NAR cancer 6 (2) (2024)
Pia Hoellerbauer, Megan Kufeld, Sonali Arora, Kelly Mitchell, Emily J Girard, Jacob A Herman, James M Olson, Patrick J Paddison
FBXO42 activity is required to prevent mitotic arrest, spindle assembly checkpoint activation and lethality in glioblastoma and other cancers. NAR cancer 6 (2) (2024)
Anwesha Dasgupta, John R Prensner
Upstream open reading frames: new players in the landscape of cancer gene regulation. NAR cancer 6 (2) (2024)
Anwesha Dasgupta, John R Prensner
Upstream open reading frames: new players in the landscape of cancer gene regulation. NAR cancer 6 (2) (2024)
Mélanie Mahé, Tiffany Rios-Fuller, Olga Katsara, Robert J Schneider
Non-canonical mRNA translation initiation in cell stress and cancer. NAR cancer 6 (2) (2024)
Yoshiaki Yasumizu, Masaki Hagiwara, Yuto Umezu, Hiroaki Fuji, Keiko Iwaisako, Masataka Asagiri, Shinji Uemoto, Yamami Nakamura, Sophia Thul, Azumi Ueyama, Kazunori Yokoi, Atsushi Tanemura, Yohei Nose, Takuro Saito, Hisashi Wada, Mamoru Kakuda, Masaharu Kohara, Satoshi Nojima, Eiichi Morii, Yuichiro Doki, Shimon Sakaguchi, Naganari Ohkura
Neural-net-based cell deconvolution from DNA methylation reveals tumor microenvironment associated with cancer prognosis. NAR cancer 6 (2) (2024)
Yoshiaki Yasumizu, Masaki Hagiwara, Yuto Umezu, Hiroaki Fuji, Keiko Iwaisako, Masataka Asagiri, Shinji Uemoto, Yamami Nakamura, Sophia Thul, Azumi Ueyama, Kazunori Yokoi, Atsushi Tanemura, Yohei Nose, Takuro Saito, Hisashi Wada, Mamoru Kakuda, Masaharu Kohara, Satoshi Nojima, Eiichi Morii, Yuichiro Doki, Shimon Sakaguchi, Naganari Ohkura
Neural-net-based cell deconvolution from DNA methylation reveals tumor microenvironment associated with cancer prognosis. NAR cancer 6 (2) (2024)
Sseu-Pei Hwang, Catherine Denicourt
The impact of ribosome biogenesis in cancer: from proliferation to metastasis. NAR cancer 6 (2) (2024)
Xingyuan Zhang, Sayali Joseph, Di Wu, Jessica L Bowser, Cyrus Vaziri
The DNA Damage Response (DDR) landscape of endometrial cancer defines discrete disease subtypes and reveals therapeutic opportunities. NAR cancer 6 (2) (2024)
Hongbo Ling, Yixuan Li, Changmin Peng, Shengyu Yang, Edward Seto
HDAC10 inhibition represses melanoma cell growth and BRAF inhibitor resistance via upregulating SPARC expression. NAR cancer 6 (2) (2024)
Fabien Aubé, Nicolas Fontrodona, Laura Guiguettaz, Elodie Vallin, Lucilla Fabbri, Audrey Lapendry, Stephan Vagner, Emiliano P Ricci, Didier Auboeuf
Metabolism-dependent secondary effect of anti-MAPK cancer therapy on DNA repair. NAR cancer 6 (2) (2024)
Fabien Aubé, Nicolas Fontrodona, Laura Guiguettaz, Elodie Vallin, Lucilla Fabbri, Audrey Lapendry, Stephan Vagner, Emiliano P Ricci, Didier Auboeuf
Metabolism-dependent secondary effect of anti-MAPK cancer therapy on DNA repair. NAR cancer 6 (2) (2024)
Nicholas Manguso, Minhyung Kim, Neeraj Joshi, Md Rasel Al Mahmud, Juan Aldaco, Ryusuke Suzuki, Felipe Cortes-Ledesma, Xiaojiang Cui, Shintaro Yamada, Shunichi Takeda, Armando Giuliano, Sungyong You, Hisashi Tanaka
TDP2 is a regulator of estrogen-responsive oncogene expression. NAR cancer 6 (2) (2024)
Sseu-Pei Hwang, Catherine Denicourt
The impact of ribosome biogenesis in cancer: from proliferation to metastasis. NAR cancer 6 (2) (2024)
Hongbo Ling, Yixuan Li, Changmin Peng, Shengyu Yang, Edward Seto
HDAC10 inhibition represses melanoma cell growth and BRAF inhibitor resistance via upregulating SPARC expression. NAR cancer 6 (2) (2024)
Hongbo Ling, Yixuan Li, Changmin Peng, Shengyu Yang, Edward Seto
HDAC10 inhibition represses melanoma cell growth and BRAF inhibitor resistance via upregulating SPARC expression. NAR cancer 6 (2) (2024)
Nicholas Manguso, Minhyung Kim, Neeraj Joshi, Md Rasel Al Mahmud, Juan Aldaco, Ryusuke Suzuki, Felipe Cortes-Ledesma, Xiaojiang Cui, Shintaro Yamada, Shunichi Takeda, Armando Giuliano, Sungyong You, Hisashi Tanaka
TDP2 is a regulator of estrogen-responsive oncogene expression. NAR cancer 6 (2) (2024)

volume 6, number 3, 2024

Camilla Coulson-Gilmer, Samantha Littler, Bethany M Barnes, Rosie M Brady, Holda A Anagho, Nisha Pillay, Malini Dey, William Macmorland, Daniel Bronder, Louisa Nelson, Anthony Tighe, Wei-Hsiang Lin, Robert D Morgan, Richard D Unwin, Michael L Nielsen, Joanne C McGrail, Stephen S Taylor
Intrinsic PARG inhibitor sensitivity is mimicked by TIMELESS haploinsufficiency and rescued by nucleoside supplementation. NAR cancer 6 (3) (2024)
Achyut Bora, Ritesh Pal, Chandra Sova Mandi, Sanjay Dutta
DNA abasic sites act as rational therapeutic targets to synergize temozolomide response in both MMR-proficient and deficient cancer. NAR cancer 6 (3) (2024)
Achyut Bora, Ritesh Pal, Chandra Sova Mandi, Sanjay Dutta
DNA abasic sites act as rational therapeutic targets to synergize temozolomide response in both MMR-proficient and deficient cancer. NAR cancer 6 (3) (2024)
Jacob Fessler, Stephanie Ting, Hong Yi, Santiago Haase, Jingting Chen, Saygin Gulec, Yue Wang, Nathan Smyers, Kohen Goble, Danielle Cannon, Aarav Mehta, Christina Ford, Elizabeth Brunk
CytoCellDB: a comprehensive resource for exploring extrachromosomal DNA in cancer cell lines. NAR cancer 6 (3) (2024)
Lijun Xu, Brett Liddell, Ksenija Nesic, Franziska Geissler, Lauren M Ashwood, Matthew J Wakefield, Clare L Scott, Nicola Waddell, Olga Kondrashova
High-level tumour methylation of BRCA1 and RAD51C is required for homologous recombination deficiency in solid cancers. NAR cancer 6 (3) (2024)
Lijun Xu, Brett Liddell, Ksenija Nesic, Franziska Geissler, Lauren M Ashwood, Matthew J Wakefield, Clare L Scott, Nicola Waddell, Olga Kondrashova
High-level tumour methylation of BRCA1 and RAD51C is required for homologous recombination deficiency in solid cancers. NAR cancer 6 (3) (2024)
Sofia Ramalho, Anna Dopler, William James Faller
Ribosome specialization in cancer: a spotlight on ribosomal proteins. NAR cancer 6 (3) (2024)
Sofia Ramalho, Anna Dopler, William James Faller
Ribosome specialization in cancer: a spotlight on ribosomal proteins. NAR cancer 6 (3) (2024)
Camilla Coulson-Gilmer, Samantha Littler, Bethany M Barnes, Rosie M Brady, Holda A Anagho, Nisha Pillay, Malini Dey, William Macmorland, Daniel Bronder, Louisa Nelson, Anthony Tighe, Wei-Hsiang Lin, Robert D Morgan, Richard D Unwin, Michael L Nielsen, Joanne C McGrail, Stephen S Taylor
Intrinsic PARG inhibitor sensitivity is mimicked by TIMELESS haploinsufficiency and rescued by nucleoside supplementation. NAR cancer 6 (3) (2024)
Jacob Fessler, Stephanie Ting, Hong Yi, Santiago Haase, Jingting Chen, Saygin Gulec, Yue Wang, Nathan Smyers, Kohen Goble, Danielle Cannon, Aarav Mehta, Christina Ford, Elizabeth Brunk
CytoCellDB: a comprehensive resource for exploring extrachromosomal DNA in cancer cell lines. NAR cancer 6 (3) (2024)
Francesca Aguilo, Erik Dassi
Editorial: Translational control in cancer. NAR cancer 6 (3) (2024)
Francesca Aguilo, Erik Dassi
Editorial: Translational control in cancer. NAR cancer 6 (3) (2024)
Pedro Fuentes, Joffrey Pelletier, Antonio Gentilella
Decoding ribosome complexity: role of ribosomal proteins in cancer and disease. NAR cancer 6 (3) (2024)
Pedro Fuentes, Joffrey Pelletier, Antonio Gentilella
Decoding ribosome complexity: role of ribosomal proteins in cancer and disease. NAR cancer 6 (3) (2024)